Page results
-
A UCLH/UCL clinical trial of a personalised therapy for blood cancer has been expanded, meaning new groups of patients with a wider range of blood cancers are now receiving the treatment.
-
A large trial at UCLH and UCL will investigate whether a drug currently in use to treat respiratory conditions can slow the progress of Parkinson’s disease.
-
Exhibition co-curated by Healthcare Arts Collective and UCLH Arts and Heritage 25th August - 20th October 2021, UCH Street Gallery, 235 Euston Road
-
Breakthroughs in Alzheimer’s disease are exciting and invigorating dementia research, and we will need to be ready to deliver new treatments as they come through, say Professor Nick Fox and Dr Catherine Mummery.
-
UCLH has recruited the first patient to a global study of a new drug in early development, called NI0752, which is thought to reduce the production of a protein in the brain called tau.
-
This information is for patients receiving steroids for immunotherapy toxicity.
-
This page is for cancer patients receiving immunotherapy treatment.
-
Researchers at UCLH and UCL have completed the first and only randomised trial to explore a new approach to treating aggressive lung cancer.
-
Medtronic are running a series of patient webinars for anyone with Type 1 Diabetes using the MiniMed™ 780G pump or system.
-
New precision therapy for bile duct cancer extends patients’ lives
File results
-
FOI/2023/0609 - Companies that currently have contracts at UCLH
-
FOI/2023/0613 - Treatment for Melanoma
-
FOI/2023/0615 - Wayfinding strategy
-
FOI/2023/0617 - Neonatal unit CCTV
-
FOI/2023/0623 - BMA rate card rates
-
FOI/2023/0635 - Redundancy consultation
-
FOI/2023/0637 - Trust’s policy/eligibility for treatment at Eastman Dental Hospital
-
FOI/2023/0647 - Radiation Protection Supervisor
-
FOI/2023/0648 - Robotic Process Automation (RPA)
-
FOI/2023/0649 - Maternity Information Systems (MIS)